GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial shift in how we approach high blood sugar. These new medications function to mimicking the body’s own GLP-1 https://aronhewb406203.canariblogs.com/glp-1-a-significant-advance-in-diabetes-management-56907509